NCT00799006 - A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Overweight

Interventions

DRUG

Placebo

Subjects will be given placebo or PF-04620110

DRUG

PF-04620110

A single oral dose of PF-04620110 will be given. The specific dose will depend on the cohort to which the subject is assigned and the period of the cross-over for that cohort. Initial planned doses are 0.3-30 mg but may be modified based on emerging PK and safety data.

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven